XOMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.51 USD | +0.73% |
|
+0.52% | +0.39% |
| 06-12 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
| 05-09 | Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M | MT |
Chart calendar XOMA Corporation
6f444f4f9e7.yvD4WCWyxeraJxB1CJ5Ud7WD1HDERr4BXiuQ-8hc-mM.goGZbVXZv421U2cZYvMEQcLbohWuCuFRGWLkup5puxbymrxoSYSSx7deRQ~c8c71db7bb89df5d68c01eaf38cd8200
Upcoming events on XOMA Corporation
Past events on XOMA Corporation
| 2024-05-20 11:00 | H.C. Wainwright Bioconnect Investor Conference |
| 2024-05-15 12:00 | Annual General Meeting |
| 2024-05-09 07:30 | Q1 2024 Earnings Release |
| 2024-03-11 10:40 | Leerink Partners Global Biopharma Conference |
| 2024-03-08 07:30 | Q4 2023 Earnings Release |
| 2024-03-06 10:30 | TD Cowen Health Care Conference |
| 2023-11-07 07:30 | Q3 2023 Earnings Release |
| 2023-09-12 09:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-08 07:30 | Q2 2023 Earnings Release |
| 2023-05-17 12:00 | Annual General Meeting |
| 2023-05-09 07:30 | Q1 2023 Earnings Release |
| 2023-05-02 10:30 | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
| 2023-03-09 07:30 | Q4 2022 Earnings Release |
| 2023-03-07 14:10 | Cowen Health Care Conference |
| 2022-11-03 07:30 | Q3 2022 Earnings Release |
| 2022-09-12 10:00 | H.C. Wainwright Global Investment Conference |
| 2022-08-04 07:30 | Interim 2022 Earnings Release |
| 2022-05-25 10:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-18 12:00 | Annual General Meeting |
| 2022-05-05 07:30 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18,4 21,2 -13.43% | 29,4 18,9 55.27% | 38,2 37,4 2.13% | 6,03 5,60 7.63% | 4,76 6,50 -26.8% | 21,0 |
|
EBITDA Million USD | Released Forecast Spread | -3,86 -3,40 -13.53% | 12,4 9,40 32.32% | 17,5 17,7 -0.93% | -17,4 -29,9 41.78% | -40,9 -27,6 -48.36% | -9,80 |
|
EBIT Million USD | Released Forecast Spread | -3,89 -2,41 -61.05% | 12,4 2,56 384.31% | 17,5 18,0 -2.56% | -17,4 -22,8 23.45% | -41,8 -25,1 -67.06% | -8,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,98 -1,03 -91.56% | 11,8 3,40 247.38% | 15,9 15,1 5.56% | -17,1 -22,5 23.92% | -40,8 -23,6 -73.38% | -17,3 |
|
Net income Million USD | Released Forecast Spread | -1,98 -1,93 -2.45% | 8,79 4,43 98.52% | 7,79 12,5 -37.53% | -22,6 -22,5 -0.34% | -46,3 -26,3 -76.06% | -22,1 |
|
EPS USD | Released Forecast Spread | -0,23 -0,22 -4.55% | 0,78 0,41 88.71% | 0,65 1,02 -36.27% | -1,98 -1,97 -0.76% | -4,04 -2,05 -97.07% | -1,89 |
| Announcement Date | 10/03/20 | 10/03/21 | 08/03/22 | 09/03/23 | 08/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,11 3,17 -1.83% | 0,98 4,27 -76.98% | 0,45 4,52 -90.02% | 1,49 1,06 40.19% | 0,44 0,77 -42.88% | 1,66 0,80 107.25% | 0,83 1,19 -29.96% | 1,83 3,61 -49.15% | 1,49 1,34 11.47% | 9,15 | 4,67 | 5,64 |
|
EBITDA Million USD | Released Forecast Spread | -2,06 -2,30 10.3% | -4,77 3,20 -248.94% | -4,37 3,60 -221.33% | -6,21 -18,7 66.79% | -9,94 -5,40 -84.15% | -5,73 -4,80 -19.42% | -5,56 -4,40 -26.43% | -19,7 -5,70 -245.77% | -7,00 -5,30 -32.11% | 3,00 | -4,40 | -1,50 |
|
EBIT Million USD | Released Forecast Spread | -2,07 -5,15 59.93% | -4,77 -3,07 -55.33% | -4,37 -3,52 -24.17% | -6,21 -4,40 -41.14% | -10,2 -5,00 -103.4% | -5,96 -5,00 -19.14% | -5,79 -4,90 -18.1% | -19,9 -0,60 -3222.33% | -7,00 -4,95 -41.49% | 2,25 | -2,95 | -0,70 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,28 -5,35 57.41% | -4,67 -1,05 -344.34% | -4,18 -1,05 -298.92% | -5,99 -11,4 47.45% | -9,81 -5,05 -94.32% | -5,40 -4,70 -14.89% | -5,51 -4,20 -31.17% | -20,1 -2,80 -618.18% | -8,60 -7,80 -10.19% | 0,00 | -5,40 | -3,25 |
|
Net income Million USD | Released Forecast Spread | -3,65 -6,04 39.57% | -6,04 -1,51 -300.66% | -5,55 -2,40 -130.76% | -7,34 -5,40 -36% | -11,2 -5,70 -96.16% | -6,77 -6,00 -12.8% | -6,88 -5,50 -25.04% | -21,5 -4,15 -417.52% | -9,96 -9,40 -5.99% | -3,10 | -7,17 | -5,50 |
|
EPS USD | Released Forecast Spread | -0,32 -0,53 39.62% | -0,53 -0,16 -224.5% | -0,48 -0,23 -108.7% | -0,64 -1,11 42.34% | -0,98 -0,50 -97.98% | -0,59 -0,52 -13.46% | -0,60 -0,48 -25% | -1,87 -0,36 -419.44% | -0,86 -0,81 -6.17% | -0,26 | -0,61 | -0,47 |
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 08/03/24 | 09/05/24 | - | - | - |
More events
Past sector events for XOMA Corporation
| 2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XOMA Stock
- XOMAP Stock
- Calendar XOMA Corporation
